Justice Department sues one of the largest drug distributors in the U.S.

The Justice Department filed a civil lawsuit on Tuesday against one of the largest drug distributors in the U.S., AmerisourceBergen Corp., Politico reports. The DOJ alleges that the company failed to report "at least hundreds of thousands" of suspicious opioid orders to the Drug Enforcement Agency.
The Controlled Substances Act requires pharmaceutical distributors to monitor orders for controlled substances and flag any orders that seem suspicious to the DEA. AmerisourceBergen allegedly failed to report suspicious orders repeatedly since 2014, despite being notified of major "red flags" at pharmacies throughout the country, per the civil court filing. The DOJ believes that AmerisourceBergen knowingly sent drugs to at least five pharmacies they knew were engaged in suspicious behavior, including two in Florida and West Virginia where drugs "were likely being sold in parking lots for cash," per Politico.
"In the midst of a catastrophic opioid epidemic, AmerisourceBergen allegedly altered its internal systems in a way that reduced the number of orders that would be flagged as suspicious. And even up to the orders that AmerisourceBergen identified as suspicious, the company routinely failed to report those suspicious orders," Associate Attorney General Vanita Gupta said during a press call on Thursday.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
If the court finds AmerisourceBergen liable, the company could face civil penalties "potentially totaling billions of dollars," Gupta said. The company has already had to pay billions for its role in exasperating the opioid crisis, including $6.1 billion in settlements for thousands of lawsuits in February. The latest lawsuit comes as the opioid epidemic continues to plague the country. In December, the Centers for Disease Control and Prevention released a report revealing that life expectancy in the U.S. dropped for the second year in a row. Experts attribute this decline to opioid overdoses and the COVID pandemic.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
What is JD Vance's Net Worth?
In Depth The vice president is rich. But not nearly as wealthy as his boss and many of his boss' appointees
By David Faris Published
-
How to travel in the wake of a natural disaster
The Week Recommends Stay safe while being respectful
By Catherine Garcia, The Week US Published
-
How to figure out when your tax refund will arrive
The explainer How long do you have to wait between submitting your return and receiving the money?
By Becca Stanek, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
Drugmakers paid pharmacy benefit managers to avoid restricting opioid prescriptions
Under the radar The middlemen and gatekeepers of insurance coverage have been pocketing money in exchange for working with Big Pharma
By Theara Coleman, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published